Видео ютуба по тегу Runx1-Fpd

RUNX1-FPD Research Guideposts
RUNX1-FPD Research Guideposts
RUNX1 Cancer Disease Biology
RUNX1 Cancer Disease Biology
Introduction to the RUNX1-FPD imatinib Clinical Study
Introduction to the RUNX1-FPD imatinib Clinical Study
RUNX1-FPD and NIH Study Intro
RUNX1-FPD and NIH Study Intro
RUNX1 Gene Function and Risks Clip
RUNX1 Gene Function and Risks Clip
Introduction to the RUNX1-FPD imatinib Clinical Study - May 2024
Introduction to the RUNX1-FPD imatinib Clinical Study - May 2024
Module 1 - Seeds, Weeds and RUNX1-FPD: Understanding Blood Cancer Development
Module 1 - Seeds, Weeds and RUNX1-FPD: Understanding Blood Cancer Development
Intro to PCOR - Defining it for the RUNX1-FPD Community
Intro to PCOR - Defining it for the RUNX1-FPD Community
An Approach to Screen Drugs for Preventing Disease Progression in Patient with RUNX1-FPD
An Approach to Screen Drugs for Preventing Disease Progression in Patient with RUNX1-FPD
How should family members with familial RUNX1 germline mutations be monitored?
How should family members with familial RUNX1 germline mutations be monitored?
The molecular impact of RUNX1 mutations in AML
The molecular impact of RUNX1 mutations in AML
Halie's Story
Halie's Story
Dr. Brown presents: Pre-leukemic States in RUNX1 Genetic Predisposition
Dr. Brown presents: Pre-leukemic States in RUNX1 Genetic Predisposition
Berg Family Patient Spotlight
Berg Family Patient Spotlight
How Does a Genetic Mutation Lead to Cancer
How Does a Genetic Mutation Lead to Cancer
Inherited Thrombocytopenia (ITP): What Is It, Whom To Test and How To Test?
Inherited Thrombocytopenia (ITP): What Is It, Whom To Test and How To Test?
RUNX1 Patient Data Hub Demo 2: Surveys and Analysis
RUNX1 Patient Data Hub Demo 2: Surveys and Analysis
Continuity of care for patients with hematological predispositions to AML
Continuity of care for patients with hematological predispositions to AML